Market Vectors Biotech ETFBBH:PCQ:USD

Add to portfolio
Compare
Interactive chart
Historical prices
View PDF
73.01
0.688 / 0.95%
43.77 - 75.44--
Close in USDToday's change52-week range3-yr sharpe ratio
As of May 17 2013 20:59 BST.Data delayed by at least 15 minutes.

Interactive chart

ETF performance

Objective

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index is comprised of common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include small- and medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Profile

Fund typeOpen Ended Investment Company
Investment style (stocks)
Market Cap: Large
Investment Style: Growth
Morningstar categoryHealth
Launch date20/12/2011
Price currencyUSD
DomicileUnited States
SymbolBBH
Manager & start date
Hao-Hung Liao
20/12/2011
George Cao
20/12/2011

Investment

Total net assets
299.93m USDAs of Apr 30 2013
Market cap321.02m USD
Shares outstanding4.40m
Average volume (10-day)123.23k
Net expense ratio0.35%
Last dividend0.018 USD
Div yield0.02%
Div ex-date12/24/2012
Div pay-date12/31/2012
Available for saleChile, Mexico, Peru, United States

Diversification

Asset type

US stock
97.13%
Non-US stock
2.87%
Other
0.00%
Cash
0.00%
Bond
0.00%

Top 5 sectors

Healthcare
100.00%

Top 5 Regions

United States
97.13%
Eurozone
2.87%

Sector and region weightings are calculated using only long position holdings of the portfolio.

Sector & regional holdings

Top 5 holdings

Company1 year
change		Portfolio
weight		Long
allocation
Amgen Inc
AMGN:NSQ		+52.75%14.64%
Gilead Sciences Inc
GILD:NSQ		+125.47%13.83%
Celgene Corporation
CELG:NSQ		+83.42%9.37%
Biogen Idec Inc
BIIB:NSQ		+72.40%8.71%
Alexion Pharmaceuticals, Inc.
ALXN:NSQ		+22.12%4.91%
As of Mar 28 2013.Data delayed by at least 15 minutes.Top 10 holdings

The performance data shown in tables and graphs on this page is calculated in USD of the fund / index / average (as applicable), on a Bid To Bid / Nav to Nav basis, with gross dividends re-invested on ex-dividend date. Past performance is not necessarily a guide to future performance; unit prices may fall as well as rise.

All managed funds data located on FT.com is subject to the FT Terms & Conditions . All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

All data shown on this page, unless noted otherwise is Data Source and Copyright: Morningstar, Inc. 2013
All Rights reserved

© 2013 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

The Morningstar Equity Style Box is a unique graphical tool showing a fund’s true investment style and market capitalisation.

The Morningstar Fixed Income Style Box is a unique graphical tool showing a fund's true credit quality and duration.

Pricing for ETFs is the latest price and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.